Replies to post #69483 on Biotech Values

[DewDiligence]

ITMN will report results of the phase-2a ITMN-191 triple-combination study (not to be confused with the all-oral INFORM-1 study) in Jan 2009. This is a slight slip from the prior guidance of late 2008.

http://finance.yahoo.com/news/InterMune-to-Report-TopLine-prnews-13800877.html